ChemicalBook >> CAS DataBase List >>Tyrosine Kinase Inhibitor

Tyrosine Kinase Inhibitor

CAS No.
649735-46-6
Chemical Name:
Tyrosine Kinase Inhibitor
Synonyms
CS-75;Brivanib;Bms540215;Bms 540215;Unii-ddu33B674i;Brivanib, >=98%;Brivanib(BMS-540215);BMS540215; BMS 540215;Tyrosine Kinase Inhibitor;Brivanib/Tyrosine Kinase Inhibitor
CBNumber:
CB00131632
Molecular Formula:
C19H19FN4O3
Molecular Weight:
370.38
MDL Number:
MFCD13194684
MOL File:
649735-46-6.mol
MSDS File:
SDS
Last updated:2024-07-02 08:55:41

Tyrosine Kinase Inhibitor Properties

Density 1.42
storage temp. Store at -20°C
solubility insoluble in H2O; ≥18.5 mg/mL in DMSO; ≥3.39 mg/mL in EtOH with ultrasonic
form Yellow powder.
pka 14.18±0.20(Predicted)
color White to light brown
NCI Dictionary of Cancer Terms tyrosine kinase inhibitor
FDA UNII DDU33B674I

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictograms
GHS08
Signal word  Danger
Hazard statements  H360-H373-H361
Precautionary statements  P260-P314-P501-P201-P202-P281-P308+P313-P405-P501

Tyrosine Kinase Inhibitor price More Price(35)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich SML3671 Brivanib ≥98% (HPLC) 649735-46-6 5MG $119 2024-03-01 Buy
Sigma-Aldrich SML3671 Brivanib ≥98% (HPLC) 649735-46-6 25MG $479 2024-03-01 Buy
Cayman Chemical 23690 Brivanib ≥95% 649735-46-6 1mg $32 2024-03-01 Buy
Cayman Chemical 23690 Brivanib ≥95% 649735-46-6 5mg $131 2024-03-01 Buy
Cayman Chemical 23690 Brivanib ≥95% 649735-46-6 10mg $214 2024-03-01 Buy
Product number Packaging Price Buy
SML3671 5MG $119 Buy
SML3671 25MG $479 Buy
23690 1mg $32 Buy
23690 5mg $131 Buy
23690 10mg $214 Buy

Tyrosine Kinase Inhibitor Chemical Properties,Uses,Production

Uses

Brivanib is an ATP-competitive inhibitor against human VEGFR2 and FGFR with IC50 of 25 nM and 148 nM, respectively.

Definition

ChEBI: Brivanib is a secondary alcohol resulting from the hydrolysis of the carboxylic ester group of brivanib alaninate. It is a dual VEGFR-2/FGFR-1 kinase inhibitor whose alanine prodrug, brivanib alaninate is currently under development as an oral agent for the treatment of cancer. It has a role as an antineoplastic agent, an EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor, an angiogenesis inhibitor, an apoptosis inducer, a fibroblast growth factor receptor antagonist and a drug metabolite. It is a pyrrolotriazine, a fluoroindole, a diether, an aromatic ether and a secondary alcohol.

Biological Activity

brivanib is an atp competitive inhibitor of human vegfr-2 with ic50 value of 25nm [1].brivanib is a selective rtk inhibitor that targets signaling via vegfr2 and 3, and fgfr1, 2 and 3. targeting both vegf and fgf signaling pathways inhibits tumor growth in rt2 mice, with vegf signaling predominating in initiation of tumor angiogenesis, currently, brivanib therapy is being evaluated in phase iii

target

VEGFR-2

References

[1] rajeev s. bhide, zhen-wei cai, yong-zheng zhang, ligang qian, donna wei, stephanie barbosa, louis j. lombardo, robert m. borzilleri, xiaoping zheng, laurence i. wu, joel c. barrish, soong-hoon kim, kenneth leavitt, arvind mathur, leslie leith, sam chao, barri wautlet, steven mortillo, robert jeyaseelan sr., daniel kukral, john t. hunt, amrita kamath, aberra fura, viral vyas, punit marathe, celia d’arienzo, george derbin, and joseph fargnoli. discovery and preclinical studies of (r)-1-(4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan-2-ol (bms-540215), an in vivo active potent vegfr-2 inhibitor. journal of medicinal chemistry. 2006, 49 (7): 2143-2146.
[2] elizabeth allen, ian b. walters, and douglas hanahan. brivanib, a dual fgf/vegf inhibitor, is active both first and second line against mouse pancreatic neuroendocrine tumors developing adaptive/evasive resistance to vegf inhibition. clinical cancer research. 2011 (17): 5299-5310.

Tyrosine Kinase Inhibitor Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 157)Suppliers
Supplier Tel Email Country ProdList Advantage
Jinan Carbotang Biotech Co.,Ltd.
+8615866703830 figo.gao@foxmail.com China 8497 58
Hubei Jusheng Technology Co.,Ltd.
18871490254 linda@hubeijusheng.com CHINA 28172 58
BOC Sciences
+1-631-485-4226 inquiry@bocsci.com United States 19553 58
Alchem Pharmtech,Inc.
8485655694 sales@alchempharmtech.com United States 63687 58
CONIER CHEM AND PHARMA LIMITED
+8618523575427 sales@conier.com China 49374 58
career henan chemical co
+86-0371-86658258 +8613203830695 factory@coreychem.com China 29815 58
Dideu Industries Group Limited
+86-29-89586680 +86-15129568250 1026@dideu.com China 23225 58
Zhejiang J&C Biological Technology Co.,Limited
+1-2135480471 +1-2135480471 sales@sarms4muscle.com China 10473 58
InvivoChem
+1-708-310-1919 +1-13798911105 sales@invivochem.cn United States 6391 58
Hefei TNJ Chemical Industry Co.,Ltd.
+86-0551-65418684 +8618949823763 sales@tnjchem.com China 25356 58

View Lastest Price from Tyrosine Kinase Inhibitor manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
PDGFR Tyrosine Kinase Inhibitor III pictures 2024-10-30 PDGFR Tyrosine Kinase Inhibitor III
205254-94-0
US $30.00-118.00 / mg 99.64% 10g TargetMol Chemicals Inc.
LRRK2-kinase inhibitor pictures 2019-12-24 LRRK2-kinase inhibitor
1285515-21-0
US $1.00 / g 1g 99% 20kg Career Henan Chemical Co
Btk Kinase inhibitor pictures 2019-12-23 Btk Kinase inhibitor
1351636-18-4
US $1.00 / KG 1KG 99% 100KG Career Henan Chemical Co
1-[[4-[(4-Fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]oxy]-2-propanol (R)-1-(4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo(2,1-F)(1,2,4)triazin-6-yloxy)propan-2-ol 2-Propanol, 1-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-5-methylpyrrolo(2,1-F)(1,2,4)triazin-6-yl)oxy)-, (2R)- Bms 540215 Bms540215 Unii-ddu33B674i 1-[4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-propan-2(R)-ol (R)-1-(4-(4-Fluoro-2-Methyl-1H-indol-5-yloxy)-5-Methylpyrrolo[1,2-f][1,2,4]triazin-6-yloxy)propan-2-ol Brivanib(BMS-540215) Brivanib Tyrosine Kinase Inhibitor (R)-1-(4-(4-fluoro-2-Methyl-1H-indol-5-yloxy)-5-Methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan-2-ol, BSM-540215 (2R)-1-[4-(4-Fluoro-2-Methyl-1H-indol-5-yloxy)-5-Methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]propanol (2R)-1-({4-[(4-fluoro-2-Methyl-1H-indol-5-yl)oxy]-5-Methylpyrrolo[2,1-f][1,2,4]triazin-6-yl}oxy)propan-2-ol (2R)-1-[4-[(4-Fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methyl-pyrrolo[2,1-f][1,2,4]triazin-6-yl]oxypr Brivanib, >=98% (2R)-1-[4-[(4-Fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methyl-pyrrolo[2,1-f][1,2,4]triazin-6-yl]ox 1-[[4-[(4-Fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo-[2,1-f][1,2,4]triazin-6-yl]oxy]-2 CS-75 BMS540215; BMS 540215 1-[[4-[(4-Fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]oxy]-2-propanol USP/EP/BP (2R)-1-({4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpy... Brivanib/Tyrosine Kinase Inhibitor 649735-46-6 Inhibitors